Antimicrobial Resistance

Gulf Coast Consortia Antimicrobial Resistance (GCC AMR)

A collaboration of leaders in antimicrobial resistance researchers from all of GCC institutions as well as additional TMC institutions (Baylor, Rice, TAMHSC Institute for Biosciences and Technology, University of Houston, UTHealth [with the newly created UTHealth Center for Antimicrobial Resistance and Microbial Genomics], MD Anderson, UTMB Galveston, and Methodist Research Institute) have recognized the strength and potential of working together to solve the global problem of antimicrobial resistance. To this end they have formed this GCC cluster in 2016.

The GCC AMR seeks to create a robust collaborative research environment within the GCC and surrounding institutions focused on antibiotic resistance in order to increase basic, translational and patient oriented research (POR). Since the problem of AMR encompasses a variety of fields and is inherently interdisciplinary, the focus on this important problem will stimulate and strengthen collaborations among basic and clinical researchers (including clinicians) from the GCC Texas Medical Center institutions.

GCC AMR Profiles


AMR Leadership:

Cesar Arias, Chair 

Lynn Zechiedrich, Co-Chair 
Baylor College of Medicine

Tim Palzkill 
Baylor College of Medicine

Ashok Chopra 

Samuel Shelburne 
MD Anderson Cancer Center

Julian Hurdle 

Magnus Hook 

Yousif Shamoo 
Rice U.

Vincent Tam 
U. of Houston

Adriana Rosato 


AMR Faculty Profiles

Upcoming Events:

  • Antimicrobial Resistance C. diff Symposium, June 15, 2018

  • Antimicrobial Resistance Research and Stewardship, January 23-25, 2019

Previous Events:

PATRIC Bioinformatics Resource Center Workshop Featuring Pipelines and Analysis Tools for Bacterial Genomes and ‘Omics Data, March 14-16, 2018

Antimicrobial Resistance Research and Stewardship, January 17-19, 2018
2018 Conference Guide

2018 Conference Speaker Presentations

Kevin W. Garey, Pharm.D., M.S., FASHP, UH College of Pharmacy, presents “Which Antibiotics Cause C. difficile Infection?” July 13, 2017